Administration of liposomal preparation of Dauno Xome for breast cancer in patients with poor prognosis
Darskaia, E.I.; Zubarovskaia, L.S.; Afanas'ev, B.V.
Voprosy Onkologii 45(4): 440-444
1999
ISSN/ISBN: 0507-3758 PMID: 10532108 Document Number: 503159
A liposomal drug DaunoXome was used as a single agent for stage III-IV breast cancer in 9 patients. Response was recorded in 6; partial regression of tumor - 3, and stabilization of disease - in 3 cases. Nausea and vomiting were among the most frequent side-effects; stage I leukopenia was observed in 4; state II - 3, stage III - 2 patients. No. cardiotoxicity was reported.
Document emailed within 1 workday
Related Documents
Forssen, E.A.; Malé-Brune, R.; Adler-Moore, J.P.; Lee, M.J.; Schmidt, P.G.; Krasieva, T.B.; Shimizu, S.; Tromberg, B.J. 1996: Fluorescence imaging studies for the disposition of daunorubicin liposomes (Dauno Xome) within tumor tissue Cancer Research 56(9): 2066-2075Schuuring, E.; Verhoeven, E.; van Tinteren, H.; Peterse, J.L.; Nunnink, B.; Thunnissen, F.B.; Devilee, P.; Cornelisse, C.J.; van de Vijver, M.J.; Mooi, W.J. 1992: Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer Cancer Research 52(19): 5229-5234
Rudan, I.; Skorić, T.; Rudan, N. 1994: Breast cancer prognosis. I. Prognostic factors in patients with node-negative (N0) breast cancer Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 48(4-5): 159-163
Rudan, I.; Skorić, T.; Rudan, N. 1994: Breast cancer prognosis. II. Prognostic factors in patients with node-positive (N1-3) breast cancer Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 48(4-5): 165-170
Agboola, A.O.J.; Banjo, A.A.F.; Anunobi, C.C.; Ayoade, B.A.; Deji-Agboola, A.M.; Musa, A.A.; Abdel-Fatah, T.; Nolan, C.C.; Rakha, E.A.; Ellis, I.O.; Green, A.R. 2014: Molecular profiling of breast cancer in Nigerian women identifies an altered p53 pathway as a major mechanism underlying its poor prognosis compared with British counterpart Malaysian Journal of Pathology 36(1): 3-17
Umbas, R.; Isaacs, W.B.; Bringuier, P.P.; Schaafsma, H.E.; Karthaus, H.F.; Oosterhof, G.O.; Debruyne, F.M.; Schalken, J.A. 1994: Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer Cancer Research 54(14): 3929-3933
Groenendijk, R.P.; Bult, P.; Wobbes, T. 2004: Better prognosis and favorable tumor stages in patients with invasive breast mammary carcinoma after introduction of the mass screening of breast cancer in Tilburg, the Netherlands Nederlands Tijdschrift Voor Geneeskunde 148(19): 961; Author Reply 961-2
Gilbertsen, V.A. 1970: Improving the prognosis for breast cancer patients Rocky Mountain Medical Journal 67(6): 33-36
Aihara, R.; Sato, K.; Sasaki, K.; Hosaka, Y.; Narita, T. 1985: Pre and postoperative nursing of patients with bladder cancer. Nursing of a patient in the terminal stage of bladder cancer with poor prognosis Nursing Technique 31(11): 1492-1497
Semënova, N.A.; Dederer, L.I.; Gorbachëva, L.B.; Tikhomirov, A.G.; Dobreva, I.I.; Letiagin, V.P.; Laktionov, K.P. 2005: The use of 1H-NMR spectroscopy for the prognosis of overall survival of breast cancer patients Voprosy Onkologii 51(5): 581-582
Kievit, J. 2002: The effect of treatment delay on the prognosis of breast cancer patients Nederlands Tijdschrift Voor Geneeskunde 146(22): 1031-1034
Liu, J.-t.; Wei, L.-j.; Yu, J.-p.; Li, H.; Li, R.-m.; Zang, F.-l.; Sun, J.-y.; Ren, X.-b. 2011: Expression of indoleamine 2, 3-dioxygenase and its correlation with prognosis in breast cancer patients Zhonghua Zhong Liu Za Zhi 33(7): 513-516
Zhang, P.; Hou, W.; Yang, Z. 1997: Prognosis of premenopausal patients with operable breast cancer related to the timing of operation Zhonghua Zhong Liu Za Zhi 19(4): 281-283
Petit, J.Y.; Rigaut, L.; Zekri, A.; Le, M. 1989: Poor esthetic results after conservative treatment of breast cancer. Technics of partial breast reconstruction Annales de Chirurgie Plastique et Esthetique 34(2): 103-108
De Schryver, A. 1981: The effect of adjuvant radiotherapy on the prognosis of surgically treated breast cancer (a study on 960 patients) Verhandelingen - Koninklijke Academie Voor Geneeskunde van Belgie 43(6): 342-370
Cirak, Y.; Furuncuoglu, Y.; Yapicier, O.; Aksu, A.; Cubukcu, E. 2015: Aurora A overexpression in breast cancer patients induces taxane resistance and results in worse prognosis Journal of BUON: Official Journal of the Balkan Union of Oncology 20(6): 1414-1419
Huzell, L.; Persson, M.; Simonsson, M.; Markkula, A.; Ingvar, C.; Rose, C.; Jernström, H. 2015: History of oral contraceptive use in breast cancer patients: impact on prognosis and endocrine treatment response Breast Cancer Research and Treatment 149(2): 505-515
Kosaka, A.; Wani, T.; Hattori, Y.; Yamashita, A. 1982: Effect of lentinan administration of adrenalectomized rats and patients with breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 9(8): 1474-1481
Suwa, H.; Yamaguchi, A.; Taji, T.; Shimizu, H.; Masai, Y. 2019: Analysis of Five Days of Administration of S-1 Followed by a Two-Day Rest in Patients with Metastatic Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 46(3): 453-456
2006: Comparative effects of the administration period of adjuvant chemotherapy using doxifluridine (5'-DFUR) for 1 year versus 3 years after breast cancer surgery by the Shimane Breast Cancer Study Group Anticancer Research 26(1b): 591-597